STOCK TITAN

Capital One Financial (COF) Form 4 Filings

COF NYSE

Every Form 4 that Capital One Financial (COF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow COF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COF filings page.

Rhea-AI Summary

Capital One Financial (COF) insider transaction: An officer, the President of Commercial Banking, reported selling 43,200 shares of common stock on 11/06/2025 at $221.83 per share under a trading plan intended to satisfy Rule 10b5-1(c).

Following the sale, the reporting person beneficially owned 73,020 shares, held directly. The trading plan was entered on July 25, 2025, and the filing reflects a Form 4 submitted by one reporting person.

Rhea-AI Summary

Capital One Financial (COF) insider transaction: the company’s General Counsel & Corp Secy reported a sale of 2,000 shares of common stock on 11/04/2025 at a price of $219.41 per share. Following the sale, direct beneficial ownership stood at 96,486 shares.

The filing notes the transaction was executed under a Rule 10b5-1 trading plan entered on January 23, 2025. The report was filed by one reporting person and lists the ownership form as direct.

Rhea-AI Summary

Capital One Financial (COF) reported insider activity by a director and officer (Chairman and CEO). On 11/04/2025, the insider exercised 53,487 stock options at an exercise price of $63.73 and executed multiple open‑market sales the same day at weighted average prices across disclosed ranges.

The sales were executed under a Rule 10b5‑1 trading plan entered on May 13, 2025. Following these transactions, the insider beneficially owned 4,001,228 shares directly. The exercised options were originally exercisable since 02/15/2019 and carry an expiration date of 02/03/2026. Reported sale price ranges spanned from $217.56 to $221.94, with line‑item weighted averages disclosed.